Literature DB >> 8778537

Tradeoffs between quality and quantity of life: development of the QQ Questionnaire for Cancer Patient Attitudes.

A M Stiggelbout1, J C de Haes, G M Kiebert, J Kievit, J W Leer.   

Abstract

The patient's perspective is of prime concern in weighing the benefits and side effects of oncologic treatment. Little is known about patients' preference and attitudes. The authors developed a short questionnaire to assess patient attitudes concerning trade-offs between quality of life and length, or quantity, of life (the QQ Questionnaire). The questionnaire turned out to be feasible for use in various groups of cancer patients. In a factor analysis, the questionnaire was shown to consist of two factors, a Q(uality) and a L(ength) factor. Values of Cronbach's alpha for the Q and L scales (consisting of four items each) were 0.68 and 0.79, respectively. Younger patients and patients who have children assigned relatively more importance to striving for prolonged survival. Contrary to our expectation, no association was found between scores on the two scales and time tradeoff utility scores. The QQ Questionnaire can be used in research settings to study patient attitudes and the stability and determinants of patients' preferences.

Entities:  

Mesh:

Year:  1996        PMID: 8778537     DOI: 10.1177/0272989X9601600211

Source DB:  PubMed          Journal:  Med Decis Making        ISSN: 0272-989X            Impact factor:   2.583


  22 in total

1.  Physician and Patient and Caregiver Health Attitudes and Their Effect on Medicare Resource Allocation for Patients With Advanced Cancer.

Authors:  Daniel J Rocke; Halton W Beumer; Donald H Taylor; Steven Thomas; Liana Puscas; Walter T Lee
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2014-06       Impact factor: 6.223

2.  Health values of patients with bipolar disorder.

Authors:  J Tsevat; P E Keck; R W Hornung; S L McElroy
Journal:  Qual Life Res       Date:  2000       Impact factor: 4.147

3.  Predictors of satisfaction with treatment decision, decision-making preferences, and main treatment goals in patients with advanced cancer.

Authors:  Felicitas Hitz; Karin Ribi; Qiyu Li; Dirk Klingbiel; Thomas Cerny; Dieter Koeberle
Journal:  Support Care Cancer       Date:  2013-07-05       Impact factor: 3.603

4.  A multi-attribute model of prostate cancer patient's preferences for health states.

Authors:  G B Chapman; A S Elstein; T M Kuzel; R B Nadler; R Sharifi; C L Bennett
Journal:  Qual Life Res       Date:  1999-05       Impact factor: 4.147

5.  Cancer patient preferences for quality and length of life.

Authors:  Neal J Meropol; Brian L Egleston; Joanne S Buzaglo; Al B Benson; Donald J Cegala; Michael A Diefenbach; Linda Fleisher; Suzanne M Miller; Daniel P Sulmasy; Kevin P Weinfurt
Journal:  Cancer       Date:  2008-12-15       Impact factor: 6.860

Review 6.  Proposed follow up programme after curative resection for lower third oesophageal cancer.

Authors:  L H Moyes; J E Anderson; M J Forshaw
Journal:  World J Surg Oncol       Date:  2010-09-04       Impact factor: 2.754

7.  The relationship between smoking and quality of life in advanced lung cancer patients: a prospective longitudinal study.

Authors:  Sarah J Danson; Christine Rowland; Richard Rowe; Sue Ellis; Carol Crabtree; Janet M Horsman; Jonathan Wadsley; Matthew Q Hatton; Penella J Woll; Christine Eiser
Journal:  Support Care Cancer       Date:  2015-09-12       Impact factor: 3.603

8.  Reasons for non-standard treatment in elderly patients with advanced head and neck cancer.

Authors:  W Derks; J R J de Leeuw; G J Hordijk; J A M Winnubst
Journal:  Eur Arch Otorhinolaryngol       Date:  2004-03-11       Impact factor: 2.503

9.  Expected survival with and without second-line palliative chemotherapy: who wants to know?

Authors:  Linda J M Oostendorp; Petronella B Ottevanger; Agnes J van de Wouw; Ivonne J H Schoenaker; Hiltje de Graaf; Winette T A van der Graaf; Peep F M Stalmeier
Journal:  Health Expect       Date:  2014-10-10       Impact factor: 3.377

10.  Economic evaluation of plerixafor for stem cell mobilization.

Authors:  Steven M Kymes; Iskra Pusic; Dennis L Lambert; Martin Gregory; Kenneth R Carson; John F DiPersio
Journal:  Am J Manag Care       Date:  2012-01       Impact factor: 2.229

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.